Metabolomic and gut microbial biomarkers of smoking cessation treatment in long-term drug therapy: a study protocol for a randomized controlled trial

cbtpapercliniciantier 3link ok

Open source

Overview

AI-generated summary, not a substitute for reading the source.

This study protocol outlines a randomized controlled trial investigating the effects of a six-week CBT smoking cessation intervention on individuals with Substance Use Disorders. The research aims to analyze changes in metabolic profiles, gut microbiome markers, and psychobehavioral outcomes compared to a treatment-as-usual control group. It is designed for researchers interested in the biological mechanisms linking addiction, smoking cessation, and long-term psychiatric medication use.

ID
14e4facd403240ba
Source org
PubMed Central
Author
Johannes Peter (Sigmund Freud Privatuniversität Wien), Alina Pritz (University Clinic of Traumatology), Michaela Hiebler (Addiction Switzerland), Mahdi Mahmoudi (Sigmund Freud Privatuniversität - Standort Mailand), Jürgen Fuchshuber (Comprehensive Cancer Center Vienna), Sabrina Mörkl (Medical University of Graz), Sandra Holasek (Medical University of Graz), Elke Humer (Sigmund Freud Privatuniversität Wien), ­Human‐Friedrich Unterrainer (Sigmund Freud Privatuniversität Wien)
Published
2026-03-03
OA status
gold
DOI
10.3389/fpsyt.2026.1677235
PMID
Not recorded
PMCID
Not recorded
Citations
0

Tags

Verification

Automated checks only, not clinical endorsement or advice.

Cite this entry

BibTeX

@article{allodium:14e4facd403240ba,
  title = {Metabolomic and gut microbial biomarkers of smoking cessation treatment in long-term drug therapy: a study protocol for a randomized controlled trial},
  author = {Johannes Peter and Alina Pritz and Michaela Hiebler and Mahdi Mahmoudi and Jürgen Fuchshuber and Sabrina Mörkl and Sandra Holasek and Elke Humer and ­Human‐Friedrich Unterrainer},
  year = {2026},
  journal = {PubMed Central},
  doi = {10.3389/fpsyt.2026.1677235},
  url = {https://doi.org/10.3389/fpsyt.2026.1677235}
}

RIS

TY  - JOUR
TI  - Metabolomic and gut microbial biomarkers of smoking cessation treatment in long-term drug therapy: a study protocol for a randomized controlled trial
AU  - Peter, Johannes
AU  - Pritz, Alina
AU  - Hiebler, Michaela
AU  - Mahmoudi, Mahdi
AU  - Fuchshuber, Jürgen
AU  - Mörkl, Sabrina
AU  - Holasek, Sandra
AU  - Humer, Elke
AU  - Unterrainer, ­Human‐Friedrich
PY  - 2026
PB  - PubMed Central
DO  - 10.3389/fpsyt.2026.1677235
UR  - https://doi.org/10.3389/fpsyt.2026.1677235
ER  -

APA

Peter, J., Pritz, A., Hiebler, M., Mahmoudi, M., Fuchshuber, J., Mörkl, S., Holasek, S., Humer, E., & Unterrainer, ­. (2026). Metabolomic and gut microbial biomarkers of smoking cessation treatment in long-term drug therapy: a study protocol for a randomized controlled trial. PubMed Central. https://doi.org/10.3389/fpsyt.2026.1677235

Related entries

More like this